U.S. Online Retail and Ecommerce Stock News

If you are wondering whether Exact Sciences at around $101 a share is still a smart buy or if the easy money has already been made, you are not alone and that is exactly what we are going to unpack. The stock has climbed 50.2% over the last month and is up 78.1% year to date, while still carrying a 127.2% gain over 3 years despite being 25.5% lower than 5 years ago, a rollercoaster that clearly signals shifting views on its growth potential and risk. Much of that renewed enthusiasm has been...

Ciena (CIEN) just put some numbers behind the excitement, issuing upbeat revenue guidance for the first quarter and full fiscal 2026 that leans on rising Cloud and AI network demand. See our latest analysis for Ciena. The upbeat guidance has supercharged sentiment, with Ciena’s share price jumping 9.25% in the last session and delivering a 90 day share price return of 84.62%, while its 1 year total shareholder return of 186.76% and 3 year total shareholder return of 399.42% show that this...

Rhythm Pharmaceuticals recently announced positive preliminary data from an exploratory Phase 2 trial of setmelanotide in Prader-Willi syndrome, reporting reductions in BMI and hyperphagia and indicating plans to advance to a Phase 3 registrational study. The company is also extending its Prader-Willi program with a Phase 1, Part D study of weekly MC4R agonist RM-718, signaling a broader, multi-asset approach to this rare obesity indication. Next, we’ll examine how setmelanotide’s...

Warner Music Group (WMG) just handed the creative keys to longtime A&R heavyweight Craig Kallman, naming him Chief Music Officer and tasking him with shaping artist development across the entire global roster. See our latest analysis for Warner Music Group. The appointment of Kallman as Chief Music Officer lands at a tricky market moment, with Warner Music Group’s 1 month share price return of -8.45 percent and 1 year total shareholder return of -12.85 percent pointing to fading momentum...

AngloGold Ashanti (NYSE:AU) heads into its Resourcing Tomorrow conference appearance with a timely backdrop, a 20% jump in gold production and reaffirmed multi year output guidance that puts the Sukari acquisition firmly in focus for investors. See our latest analysis for AngloGold Ashanti. That production jump and confident guidance seem to be feeding into sentiment, with the share price up 7.75% over the past month and a powerful 251.27% year to date share price return. The 3 year total...

Ferrari (RACE) has quietly slipped about 13% over the past month and roughly 23% in the past 3 months, even as revenue and net income keep growing at mid single digit rates. See our latest analysis for Ferrari. Zooming out, the recent 1 month and 3 month share price pullback contrasts with a still strong 3 year total shareholder return. This suggests momentum has cooled, but the longer term Ferrari story remains intact. If Ferrari’s recent slide has you reassessing the auto space, it could be...

Burlington Stores (BURL) is getting fresh attention after management nudged its 2026 expansion plans higher, lifting the target to 110 net new stores, supported by 45 leases picked up from Joann Fabrics’ bankruptcy. See our latest analysis for Burlington Stores. The expansion news lands at a mixed moment for the stock, with a recent 7 day share price return of 4.9% helping to offset a weaker year to date share price return and a modestly negative 1 year total shareholder return. At the same...

In recent days, Deutsche Bank downgraded Norfolk Southern to a Hold rating, signaling increased caution around the railroad operator’s outlook and operations. At the same time, a meaningful reduction in short interest suggests some bearish investors have scaled back their positions, hinting at a shift in market sentiment. We’ll now examine how Deutsche Bank’s downgrade may influence Norfolk Southern’s existing investment narrative and future risk‑reward balance. Uncover the next big thing...

Earlier this month, several analysts upgraded Lear Corporation after management indicated fourth-quarter 2025 results should land at the upper end of guidance and flagged a return to positive revenue and earnings growth next year, supported by reshoring, deeper Chinese OEM exposure and automation-led cost savings. At the same time, one major bank downgraded its rating, so the overall picture now reflects growing optimism around Lear’s operational improvements while still highlighting...

Kewaunee Scientific (KEQU) has just turned in a mixed Q2 2026 scorecard, posting revenue of about $70.1 million and EPS of $0.85 as profitability continues to reflect a narrower net margin profile than a year ago. The company has seen quarterly revenue move from $47.8 million in Q2 2025 to $70.1 million in Q2 2026, while quarterly EPS has swung between $0.47 and $1.70 over the same stretch, underscoring how choppy earnings have become as margins compressed from last year’s levels. See our...

Earlier this month, The GEO Group Inc. announced that long‑time Senior Vice President, Legal Services, General Counsel, and Corporate Secretary Joe Negron will retire effective December 31, 2025, after serving in his current roles since 2019, and will remain as a consultant on legal, regulatory, and compliance matters for two years starting January 1, 2026. This transition keeps Negron’s institutional and regulatory expertise tied to GEO as investor attention increasingly centers on the...

Praxis Precision Medicines (PRAX) just checked several big regulatory boxes, with the FDA signaling a path toward New Drug Applications for relutrigine and ulixacaltamide while elsunersen’s EMBRAVE3 trial shifts into a faster single arm design. See our latest analysis for Praxis Precision Medicines. Those rapid fire regulatory wins have gone hand in hand with a powerful rerating, with Praxis posting a roughly 609% 3 month share price return and a 627% 3 year total shareholder return,...

T. Rowe Price Group recently reported that its assets under management stood at US$1.79 trillion at the end of November, alongside US$8.0 billion in net client outflows for the month, while also reshaping operations with a new Technology, Data, and Operations function. These sizable outflows, combined with organizational changes and ongoing investment in technology and global distribution, highlight the tension between the firm’s strong retirement franchise and current pressure on organic...

Repligen (RGEN) is back in focus after fresh coverage spotlighted a growing disconnect between its acquisition driven expansion and softer organic revenue growth, along with a clear slide in operating margins. See our latest analysis for Repligen. The latest note seems to have cooled sentiment a little, with a modest pullback in the 7 day share price return after a strong 90 day share price rally and only lukewarm 1 year total shareholder return. This hints that momentum is still rebuilding...

Daktronics (DAKT) just stacked several important updates into one quarter, combining solid Q2 sales and order growth with a deeper product backlog, a new CEO on deck, and expanded manufacturing capacity. See our latest analysis for Daktronics. That operational momentum is starting to show up in the market too, with the share price at around $20.51 and a robust year to date share price return of roughly 23%, building on a remarkable three year total shareholder return above 700%. If Daktronics...

If you are wondering whether Cleveland-Cliffs at around $13.41 is a bargain or a value trap right now, you are not alone. This breakdown is designed to help you cut through the noise. The stock has risen about 5.2% over the last week and 31.5% over the past month, and is now up 40.6% year to date, even though longer-term returns over 3 and 5 years remain slightly negative. Recent headlines have focused on shifting steel demand expectations, ongoing trade policy discussions, and...

Noble (NYSE:NE) just made a decisive move, agreeing to sell six jackup rigs and lean harder into deepwater and ultra harsh work, a shift that could meaningfully reshape its risk profile and cash generation. See our latest analysis for Noble. Those jackup sales land after a choppy stretch, with the share price down year to date but still delivering a positive one year total shareholder return. This suggests sentiment is cautious even as interest in Noble’s streamlined, deepwater focused story...

In early December 2025, BitMine Immersion Technologies disclosed that it had purchased more than 138,000 ether in a week, lifting its Ethereum treasury to about 3.86 million ETH and over US$13.20 billion in combined crypto and cash assets, or more than 3.2% of Ethereum’s circulating supply. Beyond amassing the world’s largest corporate Ethereum position, BitMine is targeting control of 5% of the ETH supply and preparing a US-based staking infrastructure launch in 2026, signaling ambitions...

If you are wondering whether United Parcel Service is a bargain or a value trap at current levels, you are not alone. This breakdown is designed to cut through the noise for long-term investors. Despite a tough longer-term picture, with the stock down 18.9% year to date and 16.7% over the past year, UPS has bounced 6.0% in the last week and 5.7% over the past month as sentiment has started to thaw. That shift comes as investors refocus on UPS's leverage to global e-commerce volumes and the...

Tandem Diabetes Care (TNDM) is back in focus after fresh commentary underscored two pressure points: soft insulin pump demand over the past couple of years and a still negative EBITDA profile that limits financial flexibility. See our latest analysis for Tandem Diabetes Care. Despite those concerns, the market has started to rethink Tandem’s prospects, with a 30 day share price return of 19.69 percent and a striking 90 day share price return of 70.90 percent. However, the 1 year total...

Wondering if Campbell's dip has finally turned this pantry staple into a genuine value opportunity, or if it is a value trap in disguise? The stock has slid about 3.2% over the last week and roughly 9.9% over the past month, capping off a much steeper slide of around 32.4% year to date and 30.8% over the last year. Recent headlines have focused on shifting consumer spending habits, with shoppers trading between brand names and private labels, as well as ongoing debates about how inflation...

Earlier this month, UBS initiated coverage on Stifel Financial with a positive analyst rating, highlighting the firm’s evolution into a globally competitive wealth manager, investment bank, and brokerage under CEO Ronald Kruszewski, following a series of acquisitions. This endorsement from a major global institution underscores how Stifel’s multi-year transformation and diversified business model are increasingly drawing attention from large, institutional research desks. Now we’ll examine...

Cisco Systems (CSCO) has quietly put together a steady run, with shares up roughly 19% over the past 3 months and about 38% over the past year, drawing fresh attention from long term investors. See our latest analysis for Cisco Systems. That steady climb to a recent share price of $79.27, including a roughly double digit 30 day share price return and a strong multi year total shareholder return, suggests momentum is building as investors warm to Cisco’s growth and earnings profile. If Cisco’s...

Earlier this week, Align Technology launched commercial availability in Thailand of its Invisalign System with mandibular advancement and integrated occlusal blocks, its first clear aligner specifically designed to correct Class II skeletal and dental issues by advancing the lower jaw while straightening teeth. This product not only broadens Align’s Class II treatment options for children and teenagers, but also extends access across key Asia-Pacific markets, including Australia, China,...